[Characteristics of Guérin carcinoma and its drug-resistant variant].
D000818:Animals; D002277:Carcinoma / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004273:DNA, Neoplasm / Q000378:metabolism; D008058:Dihydrolipoamide Dehydrogenase / Q000378:metabolism; D004351:Drug Resistance; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D006651:Histocytochemistry; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D009113:Muramidase / Q000378:metabolism; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000201:enzymology / Q000378:metabolism; D012334:RNA, Neoplasm / Q000378:metabolism; D051381:Rats; D013438:Sulfhydryl Compounds / Q000378:metabolism
D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D013438:Sulfhydryl Compounds; D003520:Cyclophosphamide; D007770:L-Lactate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D008058:Dihydrolipoamide Dehydrogenase; D009113:Muramidase
Osobennosti kartsinomy Gerena i ee lekerstvennoustoĭchivogo varianta.